These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18221394)

  • 1. Effect of long-term cabergoline therapy on the immunological pattern and pituitary function of patients with idiopathic hyperprolactinaemia positive for antipituitary antibodies.
    De Bellis A; Colao A; Savoia A; Coronella C; Pasquali D; Conte M; Pivonello R; Bellastella A; Sinisi AA; Bizzarro A; Lombardi G; Bellastella G
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):285-91. PubMed ID: 18221394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipituitary antibodies in idiopathic hyperprolactinemic patients.
    De Bellis A; Colao A; Pivonello R; Savoia A; Battaglia M; Ruocco G; Tirelli G; Lombardi G; Bellastella A; Bizzarro A
    Ann N Y Acad Sci; 2007 Jun; 1107():129-35. PubMed ID: 17804540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipituitary antibodies in adults with apparently idiopathic growth hormone deficiency and in adults with autoimmune endocrine diseases.
    De Bellis A; Bizzarro A; Conte M; Perrino S; Coronella C; Solimeno S; Sinisi AM; Stile LA; Pisano G; Bellastella A
    J Clin Endocrinol Metab; 2003 Feb; 88(2):650-4. PubMed ID: 12574195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of antipituitary antibodies targeting pituitary hormone-secreting cells in idiopathic growth hormone deficiency and autoimmune endocrine diseases.
    De Bellis A; Bizzarro A; Perrino S; Coronella C; Conte M; Pasquali D; Sinisi AA; Betterle C; Bellastella A
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):45-9. PubMed ID: 15963060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antipituitary antibodies in patients with suspected autoimmune hypophysitis].
    Moya Chimenti E; Alvarez Doforno R; Villaroel Bajo A; Frutos R; Pallardo Sánchez LF; Alvarez Escolá C
    Endocrinol Nutr; 2010 Apr; 57(4):160-4. PubMed ID: 20385514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of remission of hyperprolactinaemia after long-term withdrawal of cabergoline therapy.
    Colao A; Di Sarno A; Guerra E; Pivonello R; Cappabianca P; Caranci F; Elefante A; Cavallo LM; Briganti F; Cirillo S; Lombardi G
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):426-33. PubMed ID: 17573902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy.
    Di Sarno A; Landi ML; Cappabianca P; Di Salle F; Rossi FW; Pivonello R; Di Somma C; Faggiano A; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5256-61. PubMed ID: 11701688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipituitary antibodies against gonadotropin-secreting cells in adult male patients with apparently idiopathic hypogonadotropic hypogonadism.
    De Bellis A; Sinisi AA; Conte M; Coronella C; Bellastella G; Esposito D; Pasquali D; Ruocco G; Bizzarro A; Bellastella A
    J Clin Endocrinol Metab; 2007 Feb; 92(2):604-7. PubMed ID: 17090639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cabergoline on hyperprolactinemia, psychopathology, and sexual functioning in schizophrenic patients.
    Kalkavoura CS; Michopoulos I; Arvanitakis P; Theodoropoulou P; Dimopoulou K; Tzebelikos E; Lykouras L
    Exp Clin Psychopharmacol; 2013 Aug; 21(4):332-41. PubMed ID: 23834553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cabergoline and hyperprolactinaemia: new preparation. Better than bromocriptine.
    Prescrire Int; 2000 Feb; 9(45):195-7. PubMed ID: 11503793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancy.
    Ciccarelli E; Grottoli S; Razzore P; Gaia D; Bertagna A; Cirillo S; Cammarota T; Camanni M; Camanni F
    J Endocrinol Invest; 1997 Oct; 20(9):547-51. PubMed ID: 9413809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipituitary antibodies in dutch patients with idiopathic hypopituitarism.
    de Graaff LC; De Bellis A; Bellastella A; Hokken-Koelega AC
    Horm Res; 2009 Jan; 71(1):22-7. PubMed ID: 19039233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender effects on cardiac valvular function in hyperprolactinaemic patients receiving cabergoline: a retrospective study.
    Nachtigall LB; Valassi E; Lo J; McCarty D; Passeri J; Biller BM; Miller KK; Utz A; Grinspoon S; Lawson EA; Klibanski A
    Clin Endocrinol (Oxf); 2010 Jan; 72(1):53-8. PubMed ID: 19508591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of short-term maintenance treatment with cabergoline in microadenoma-related and idiopathic hyperprolactinemia.
    Buyukbayrak EE; Karageyim Karsidag AY; Kars B; Balcik O; Pirimoglu M; Unal O; Turan C
    Arch Gynecol Obstet; 2010 Nov; 282(5):561-6. PubMed ID: 20571820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
    Rains CP; Bryson HM; Fitton A
    Drugs; 1995 Feb; 49(2):255-79. PubMed ID: 7729332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological response modifiers of cancer-related neuroendocrine disorders: efficacy of the long-term dopaminergic agonist cabergoline in the treatment of breast cancer-induced hyperprolactinemia.
    Lissoni P; Vaghi M; Pescia S; Rovelli F; Ardizzola A; Valtulina F; Malugani F; Gardani G; Tancini G
    J Biol Regul Homeost Agents; 2004; 18(3-4):291-4. PubMed ID: 15786695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipituitary antibodies recognizing growth hormone (GH)-producing cells in children with idiopathic GH deficiency and in children with idiopathic short stature.
    De Bellis A; Salerno M; Conte M; Coronella C; Tirelli G; Battaglia M; Esposito V; Ruocco G; Bellastella G; Bizzarro A; Bellastella A
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2484-9. PubMed ID: 16621907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of constrictive pericarditis during cabergoline treatment for hyperprolactinaemia.
    Löndahl M; Nilsson A; Lindgren H; Katzman P
    Eur J Endocrinol; 2008 Apr; 158(4):583-5. PubMed ID: 18362307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of 100 pregnancies initiated under treatment with cabergoline in hyperprolactinaemic women.
    Lebbe M; Hubinont C; Bernard P; Maiter D
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):236-42. PubMed ID: 20455894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipituitary antibodies after traumatic brain injury: is head trauma-induced pituitary dysfunction associated with autoimmunity?
    Tanriverdi F; De Bellis A; Bizzarro A; Sinisi AA; Bellastella G; Pane E; Bellastella A; Unluhizarci K; Selcuklu A; Casanueva FF; Kelestimur F
    Eur J Endocrinol; 2008 Jul; 159(1):7-13. PubMed ID: 18463108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.